Cincinnati, OHNCT07015437Now EnrollingIRB Ready

Blood Transfusion Clinical Trial in Cincinnati, OH

Access cutting-edge blood transfusion treatment through this phase 2 clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.

Sponsored by Cerus Corporation

Quick Self-Assessment

See if you qualify for this Cincinnati location

Preparing your pre-screening questions…

Expert Care in Cincinnati

Access blood transfusion specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related blood transfusion treatment provided free

Apply for This Cincinnati Location

Check if you qualify for this blood transfusion clinical trial in Cincinnati, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cincinnati

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cincinnati site if eligible
  4. 4Begin participation

About This Blood Transfusion Study in Cincinnati

The objective of this trial is to assess the post-infusion viability of INTERCEPT RBCs by measuring the 24-hour post-infusion recovery and lifespan of autologous RBCs prepared with the INTERCEPT Blood System for RBC with AS-1 after 35 days post collection storage in comparison to untreated AS-1 RBCs stored for 35 days.

Sponsor: Cerus Corporation

Who Can Participate

Inclusion Criteria

Age ≥18 years
Complete blood count (CBC) and serum chemistry values within normal limits or outside of normal reference range but determined by the Investigator, and consultation with the Sponsor, to be not clinically significant.
Meet FDA, AABB, or institutional guidelines for allogeneic WB donation, including viral marker testing, with the following exceptions:
Meeting allogeneic deferral criteria due to travel, tattoos/piercings and male to male sexual contact would be acceptable, subject to the Investigator's discretion.
Subjects of childbearing potential must agree to use a medically acceptable method of contraception throughout the study.
Signed and dated informed consent form

Exclusion Criteria

History of RBC autoantibodies, autoimmune hemolytic anemia, RBC allo-antibodies, or other autoimmune disease
History of congenital red cell disorders (including self-reported glucose 6 phosphate dehydrogenase (G- 6PD) deficiency, sickle cell trait and thalassemia minor trait)
Positive DAT or IAT at study entry
Immunosuppressive therapy (e.g., oral or IV prednisone) within the past 28 days
Treatment with any medication known to affect RBC viability
Pregnant or nursing females
Participation in another interventional clinical study currently or has received an investigational drug within the past 28 days
Less than three months from receiving an infusion of a radiolabeled blood component.
Reenrollment in the same treatment group for which the subject previously contributed recovery and survival data in this study.
Non study blood component donation throughout the study
Preexisting antibody specific to INTERCEPT RBCs
History of known hypersensitivity to chromium or technetium

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cincinnati?

Yes, this clinical trial (NCT07015437) has an active research site in Cincinnati, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Blood Transfusion Treatment Options in Cincinnati, OH

If you're searching for blood transfusion treatment options in Cincinnati, OH, this clinical trial (NCT07015437) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cincinnati research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced blood transfusion specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all blood transfusion clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Cincinnati, OH

See all rheumatoid arthritis clinical trials recruiting in Cincinnati — not just this study.

Browse Rheumatoid Arthritis Trials in Cincinnati →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAll Conditions →

Ready to Join in Cincinnati?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cincinnati, OH